Menu Search
Equities

Qianhai Health Holdings Ltd

911:HKG.HZ

Qianhai Health Holdings Ltd

Actions
  • Price (HKD)0.28
  • Today's Change0.00 / 0.00%
  • Shares traded50.00
  • 1 Year change-40.43%
  • Beta--
Data delayed at least 15 minutes, as of Jun 24 2024.
More ▼
Improved Notifications for Markets Data Alerts
Improved Notifications for Markets Data Alerts
Want push notifications sent directly to your devices for equity price changes and breaking news stories? Let us know here.
 
Existing alertsView our existing alerts
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Qianhai Health Holdings Limited is an investment holding company principally engaged in the sourcing and wholesaling of American Ginseng. Along with subsidiaries, the Company operates its business through four segments. The Cultivated Ginseng segment is engaged in the purchasing and sale of cultivated American ginseng. The Wild Ginseng segment is engaged in the purchasing and sale of wild ginseng from the United States. The Ginseng Wine segment is engaged in the manufacturing and sale of ginseng wine. Its wine products include American wild ginseng brandy and American wild ginseng white spirit. The Others segment is engaged in the trading of other products, including dried cordyceps, dried cubilose, dried seafood and skin care products, among others.

  • Revenue in HKD (TTM)961.29m
  • Net income in HKD-52.71m
  • Incorporated2011
  • Employees16.00
  • Location
    Qianhai Health Holdings LtdG/F, Nam Pak Hong Commercial Centre44 Bonham Strand WestSheung Wan Hong KongHKG
  • Phone+852 25457228
  • Fax+852 25457999
  • Websitehttp://www.qianhaihealth.com.hk/
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.